Pinpoint Genomics Ready to Start Reimbursement Discussion for Lung Cancer Assay
February 15, 2012
Pinpoint Genomics Ready to Start Reimbursement Discussion for Lung Cancer Assay
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Following CLIA Lab Buy, Life Tech Jumps into MDx Space with Purchase of Pinpoint, Lung Cancer Dx
July 25, 2012 / Pharmacogenomics Reporter - Life Tech Continues to Gather Evidence Backing NSCLC Dx Pervenio, As Commercialization Progresses
February 6, 2013 / Pharmacogenomics Reporter - Life Technologies Acquires Lung Cancer Test Developer Pinpoint Genomics
July 25, 2012 / GenomeWeb Daily News - Focusing on Personalized Medicine, Pfizer Reports PGx Data for Several Oncologics at ASCO
June 9, 2010 / Pharmacogenomics Reporter - Q&A: Pfizer's Dx Division Head Discusses Pharma Giant's Focus on Personalized Medicine
September 9, 2009 / Pharmacogenomics Reporter